Back to News
Market Impact: 0.25
Tuesday's ETF Movers: XBI, CRAK
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
The State Street SPDR S&P Biotech ETF rose about 3.5% on Tuesday, outperforming other ETFs. Myriad Genetics shares gained about 37.5%, while Sagimet Biosciences shares rose about 12.4%.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
MYGN0.40
SGMT0.30
More News
- Why is Myriad Genetics stock surging today?
- A top medical technology stock is trading at a big discount. Here's why I'm buying
- Obsessed with CoreWeave and the AI trade? You're missing out on some great stocks
- MSG Sports is splitting the Knicks and Rangers into two stocks, and history says spin-offs tend to beat IPOs
- AI rally fades away from Wall Street as a tiny IPO makes big waves
- UnitedHealthcare and Humana are ending Medicare Advantage plans for nearly 1 million people
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Software for Buy-Side Teams: Build the Research Stack
- Augmented Intelligence: AllMind, Elevate Human Judgement With an Accessible, Powerful, Data-Driven Financial AI Toolkit